Eloxx Pharmaceuticals, Inc. Contracts & Agreements

207 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Stock Option Grant Notice and Stock Option Agreement (Inducement Grant) between Eloxx Pharmaceuticals, Inc. and Robert E. Ward, dated March 5, 2018
Stock Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
PRE-FUNDED COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2023
COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2023
SCHEDULE OF WARRANT HOLDERS
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2023
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Eloxx Pharmaceuticals, Inc.
2023
Eloxx Pharmaceuticals, Inc. Restricted Stock Unit Grant Notice (2018 Equity Incentive Plan)
Bonus & Incentive Agreements
Eloxx Pharmaceuticals, Inc.
2023
ELOXX PHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE (2018 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Eloxx Pharmaceuticals, Inc.
2023
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Eloxx Pharmaceuticals, Inc.
2023
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Eloxx Pharmaceuticals, Inc.
2023
Sales Agreement, dated as of May 24, 2023, by and between Eloxx Pharmaceuticals, Inc. and Oppenheimer & Co. Inc
Sales Agreements
Eloxx Pharmaceuticals, Inc.
2023
First Amendment, dated March 7, 2023, to the Loan and Security Agreement, dated as of September 30, 2021, by and among Hercules Capital, Inc., the Company, Zikani Therapeutics,...
Loan Agreements
Eloxx Pharmaceuticals, Inc.
2023
Description of Registered Securities
Eloxx Pharmaceuticals, Inc.
2022
Loan and Security Agreement, dated as of September 30, 2021, by and among Hercules Capital, Inc., the Company, Zikani Therapeutics, Inc. and the other parties thereto
Loan Agreements
Eloxx Pharmaceuticals, Inc.
2021
Sales Agreement, dated as of September 30, 2021, by and between Eloxx Pharmaceuticals, Inc. and SVB Leerink, LLC
Sales Agreements
Eloxx Pharmaceuticals, Inc.
2021
Agreement and General Release, dated as of July 2, 2021, by and between Neil S. Belloff and Eloxx Pharmaceuticals, Inc
Release Agreements
Eloxx Pharmaceuticals, Inc.
2021
Underwriting Agreement, dated May 13, 2021, by and between Eloxx Pharmaceuticals, Inc. and B. Riley Securities, Inc
Underwriting Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Employment offer letter between Eloxx Pharmaceuticals, Inc. and Gary D Rakers dated March 26, 2021
Employment Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2021
Lease agreement by and between Zikani Therapeutics, Inc. and ARE-480 Arsenal Street, LLC, dated July 28, 2015
Lease Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2021
First Amendment to Lease agreement by and between Zikani Therapeutics, Inc. and ARE-480 Arsenal Street, LLC, dated June 30, 2020
Lease Agreements
Eloxx Pharmaceuticals, Inc.
2021
Agreement and Plan of Merger, dated April 1, 2021, by and among Eloxx Pharmaceuticals, Inc., Delta Merger Sub Acquisition Corporation and Zikani Therapeutics, Inc
Merger Agreements
Eloxx Pharmaceuticals, Inc.
2021
Employment Agreement, dated as of April 1, 2021, by and between Sumit Aggarwal and Eloxx Pharmaceuticals, Inc
Employment Agreements
Eloxx Pharmaceuticals, Inc.
2021
Employment Agreement, dated as of April 1, 2021, by and between Vijay Modur and Eloxx Pharmaceuticals, Inc
Employment Agreements
Eloxx Pharmaceuticals, Inc.
2021
Separation Agreement and General Release, dated as of April 1, 2021, by and between Gregory C. Williams and Eloxx Pharmaceuticals, Inc
Separation Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
MA
2021
Executive Employment Agreement between Eloxx Pharmaceuticals, Inc. and Gregory C. Williams dated as of February 25, 2020
Employment Agreements
Eloxx Pharmaceuticals, Inc.
2020
Executive Employment Agreement between Eloxx Pharmaceuticals, Inc. and Neil Belloff dated as of February 25, 2020
Employment Agreements
Eloxx Pharmaceuticals, Inc.
2020
Employment offer letter between Eloxx Pharmaceuticals, Inc. and Stephen G. MacDonald dated as of September 24, 2019
Employment Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2020
Change in Control Severance Benefit Plan
Change of Control Agreements
Eloxx Pharmaceuticals, Inc.
2019
Underwriting Agreement by and among Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Piper Jaffray & Co., dated June 20, 2019
Underwriting Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
Underwriting Agreement by and among Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Piper Jaffray & Co., dated June 20, 2019
Underwriting Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
Executive Employment Agreement between Eloxx Pharmaceuticals, Inc. and David Snow dated as of June 18, 2018
Employment Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2019
Loan and Security Agreement, dated as of January 30, 2019, by and among Silicon Valley Bank, WestRiver Innovation Lending Fund VIII, L.P., Eloxx Pharmaceuticals, Inc., and Eloxx...
Loan Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2019
Equity Distribution Agreement, dated November 16, 2018, by and between Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Cantor Fitzgerald & Co
Equity Distribution Agreements
Eloxx Pharmaceuticals, Inc.
2018
Form of Restricted Stock Unit Grant Notice for Israeli employees
Stock Agreements
Eloxx Pharmaceuticals, Inc.
2018
Lease Amendment dated June 21, 2018
Lease Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2018
Employment Agreement with Dr. Greg Williams dated June 25, 2018
Employment Agreements
Eloxx Pharmaceuticals, Inc.
2018
Amendment to Research and License Agreement, by and among Eloxx Pharmaceuticals, Inc., Eloxx Pharmaceuticals Ltd. and Technion Research & Development Foundation Ltd., dated as of...
License Agreements
Eloxx Pharmaceuticals, Inc.
2018
Underwriting Agreement by and among Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Piper Jaffray & Co., dated April 25, 2018
Underwriting Agreements
Eloxx Pharmaceuticals, Inc.
2018
Eloxx Pharmaceuticals, Inc. 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Eloxx Pharmaceuticals, Inc. 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2018
Israeli Sub-Plan under the Eloxx Pharmaceuticals, Inc. 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2018
Form of Israeli Stock Option Grant Package under the Israeli Sub-Plan under the Eloxx Pharmaceuticals, Inc. 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Eloxx Pharmaceuticals, Inc.
2018
Specimen of Common Stock Certificate
Stock Agreements
Eloxx Pharmaceuticals, Inc.
2018
Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated August 29, 2013
License Agreements
Eloxx Pharmaceuticals, Inc.
2018
First Amendment to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated November 26, 2013
License Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2018
Second Amendment to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated January 14, 2014
License Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2018
Third Amendment to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated June 9, 2014
License Agreements
Eloxx Pharmaceuticals, Inc.
2018
First Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated August 3, 2014
License Agreements
Eloxx Pharmaceuticals, Inc.
2018
Second Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated January 21, 2015
License Agreements
Eloxx Pharmaceuticals, Inc.
2018
Third Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated February 9, 2015
License Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2018
Fourth Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated April 29, 2015
License Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2018
Fifth Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated June 2, 2015
License Agreements
Eloxx Pharmaceuticals, Inc.
2018
Sixth Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated January 11, 2016
License Agreements
Eloxx Pharmaceuticals, Inc.
2018
Seventh Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated March 6, 2016
License Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2018
Eighth Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated July 16, 2017
License Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2018
Ninth Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated July 16, 2017
License Agreements
Eloxx Pharmaceuticals, Inc.
2018
Memorandum of Understanding, dated March 13, 2018, by and between Eloxx Pharmaceuticals, Inc. and Dr. Silvia Noiman
MOUs
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
MA
2018
Employment Agreement, dated as of March 12, 2018, between Eloxx Pharmaceuticals Inc. and Gregory Weaver
Employment Agreements
Eloxx Pharmaceuticals, Inc.
2018
Employment Agreement, dated as of March 12, 2018, between Eloxx Pharmaceuticals Inc. and Pedro Huertas
Employment Agreements
Eloxx Pharmaceuticals, Inc.
2018
Eloxx Pharmaceuticals Share Ownership and Option Plan (2013)
Share Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2018
Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the Eloxx Pharmaceuticals Share Ownership and Option Plan (2013)
Stock Agreements
Eloxx Pharmaceuticals, Inc.
2018
Performance Stock Option Grant Notice and Stock Option Agreement (Inducement Grant) between Eloxx Pharmaceuticals, Inc. and Robert E. Ward, dated March 5, 2018
Bonus & Incentive Agreements
Eloxx Pharmaceuticals, Inc.
2018
Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Inducement Grant) between Eloxx Pharmaceuticals, Inc. and Robert E. Ward, dated March 5, 2018
Stock Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Performance Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Inducement Grant) between Eloxx Pharmaceuticals, Inc. and Robert E. Ward, dated March 5, 2018
Bonus & Incentive Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Lease Agreement by and between Eloxx Pharmaceuticals, Inc. and BP Pay Colony LLC, dated October 26, 2017
Lease Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Employment Agreement, dated as of December 26, 2017, between Eloxx Pharmaceuticals, Inc. and Robert E. Ward
Employment Agreements
Eloxx Pharmaceuticals, Inc.
2017
Consulting Agreement, dated December 1, 2014, by and between Eloxx Pharmaceuticals Ltd. and Dr. Silvia Noiman
Consulting Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2017
Offer to Gregory Weaver from Eloxx Pharmaceuticals Ltd., dated September 11, 2017
Eloxx Pharmaceuticals, Inc.
2017
Offer to Pedro Huertas from Eloxx Pharmaceuticals Ltd., dated April 17, 2015
Eloxx Pharmaceuticals, Inc.
2017
Form of Indemnification Agreement
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
Amendment to Agreement, dated as of November 23, 2017, by and among Sevion Therapeutics, Inc., Sevion Sub, Ltd. and Eloxx Pharmaceuticals Ltd
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2017
Amendment to Agreement, dated as of August 1, 2017, by and among Sevion Therapeutics, Inc., Sevion Sub, Ltd. and Eloxx Pharmaceuticals Ltd
Eloxx Pharmaceuticals, Inc.
2017
SUBSCRIPTIONAGREEMENT
Eloxx Pharmaceuticals, Inc.
2017
AGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2017
CONVERTIBLE PROMISSORY NOTE
Note Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
CONVERTIBLEPROMISSORY NOTE
Note Agreements
Eloxx Pharmaceuticals, Inc.
2017
AMENDED ANDRESTATED CONVERTIBLEPROMISSORY NOTE
Note Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
CONSENTAND WAIVER AGREEMENT
Waiver Agreements
Eloxx Pharmaceuticals, Inc.
2017
PREFERRED STOCK EXCHANGE AGREEMENT
Exchange Agreements
Eloxx Pharmaceuticals, Inc.
2017
SEVION THERAPEUTICS, INC. PROMISSORY NOTE
Note Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2016
SEVIONTHERAPEUTICS, Inc. AMENDMENTTO ConsultingAgreement
Eloxx Pharmaceuticals, Inc.
2016
FORM OF COMMON STOCK PURCHASE WARRANT SEVION THERAPEUTICS, INC.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2015
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2015
Nondisclosure,Noncompetition and Invention Assignment Agreement
Assignment Agreements
Eloxx Pharmaceuticals, Inc.
2015
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2015
SUBSCRIPTIONAGREEMENT
Eloxx Pharmaceuticals, Inc.
2015
SEVION THERAPEUTICS, INC. AMENDMENT NO. 1 TO SUBSCRIPTION AGREEMENT
Subscription Agreements
Eloxx Pharmaceuticals, Inc.
2015
SEVIONTHERAPEUTICS, Inc. ConsultingAgreement
Eloxx Pharmaceuticals, Inc.
2015
SUBLEASE AGREEMENT
Lease Agreements
Eloxx Pharmaceuticals, Inc.
2015
ConfidentialTreatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentialityrequest. Omissions are...
Exchange Agreements
Eloxx Pharmaceuticals, Inc.
2015
RETENTION AGREEMENT
Retention Agreements
Eloxx Pharmaceuticals, Inc.
2015
RETENTION AGREEMENT
Retention Agreements
Eloxx Pharmaceuticals, Inc.
2015
SEVIONTHERAPEUTICS, Inc. ConsultingAgreement
Eloxx Pharmaceuticals, Inc.
2015
RETENTION AGREEMENT
Retention Agreements
Eloxx Pharmaceuticals, Inc.
2014
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2014
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2014
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
2014
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2014
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2014
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
2014
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2014
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
2014
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2014
ConfidentialTreatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentialityrequest. Omissions are...
Exchange Agreements
Eloxx Pharmaceuticals, Inc.
2014
EMPLOYMENT AGREEMENT
Employment Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
CA
2014
SERIES A WARRANT AMENDMENT AGREEMENT
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2014
SERIES FA WARRANT AMENDMENT AGREEMENT
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2014
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among SENESCO TECHNOLOGIES, INC. SENESCO FAB ACQUISITION CORPORATION and FABRUS, INC. Dated as of May 16, 2014
Merger Agreements
Eloxx Pharmaceuticals, Inc.
2014
SERIES FA COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2014
SERIES FB COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2014
SERIES FC COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2014
THIS WARRANTAND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARESUBJECT TO THE RESTRICTIONS ON TRANSFERSET FORTH IN SECTION 4 OF THIS WARRANT
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2014
SERIES FE COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2014
RETENTION AGREEMENT
Retention Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2014
REVISEDBUDGET YEAR16 PERIOD:March 1, 2014 – August 31, 2014
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2014
SENESCO TECHNOLOGIES, INC. 2008 INCENTIVE COMPENSATION PLAN (As Amended and Restated February 11,2014) ARTICLE ONE GENERAL PROVISIONS
Bonus & Incentive Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2014
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2014
WARRANT AMENDMENT AGREEMENT
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2014
COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2013
COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2013
COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2013
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2013
COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2013
COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2013
COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2013
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
2013
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2013
Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are...
Exchange Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2013
Senesco Technologies, Inc. 721 Route 202/206 | Suite 130 | Bridgewater, NJ 08807 p ###-###-#### | f ###-###-#### www.senesco.com
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2013
WARRANT EXCHANGE AGREEMENT
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2013
PREFERRED STOCK EXCHANGE AGREEMENT
Exchange Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2013
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2013
Chardan Capital Markets, LLC 17 State Street, Suite 1600 New York, New York 10004
Eloxx Pharmaceuticals, Inc.
2013
WARRANT EXCHANGE AGREEMENT
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2013
COMMON STOCK PURCHASE WARRANT SENESCoTECHNOLOGIES, INC.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2013
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2013
Senesco Technologies, Inc. Retention Policy for Officers12 (Adopted by the Board on [____])
Retention Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2012
AMENDMENT TO RESEARCHAGREEMENT
Eloxx Pharmaceuticals, Inc.
2012
WARRANT EXCHANGE AGREEMENT
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
BIOFUELS EVALUATION AND LICENSE AGREEMENT
License Agreements
Eloxx Pharmaceuticals, Inc.
2012
Senesco Technologies, Inc. Common Stock Purchase Warrant (Void after [ ])
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2012
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Eloxx Pharmaceuticals, Inc.
2012
Confidential Treatment has been requestedfor portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions...
Exchange Agreements
Eloxx Pharmaceuticals, Inc.
2012
Senesco Technologies, Inc. Common Stock Purchase Warrant (Void after Janaury [__], 2017)
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2012
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Eloxx Pharmaceuticals, Inc.
2012
PROMISSORY NOTE
Note Agreements
Eloxx Pharmaceuticals, Inc.
2011
SENESCOTECHNOLOGIES, INC. CommonStock (parvalue $0.01 per share) AtMarket Issuance Sales Agreement
Share Agreements
Eloxx Pharmaceuticals, Inc.
2010
SENESCOTECHNOLOGIES, INC. 2008 INCENTIVE COMPENSATIONPLAN (AsAmended and Restated May 25, 2010) ARTICLEONE GENERALPROVISIONS
Bonus & Incentive Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2010
SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2010
Nondisclosure,Noncompetition and InventionAssignment Agreement
Eloxx Pharmaceuticals, Inc.
2010
COMMONSTOCK PURCHASE WARRANT SENESCOTECHNOLOGIES, INC.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2010
COMMONSTOCK PURCHASE WARRANT SENESCOTECHNOLOGIES, INC.
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2010
REGISTRATIONRIGHTS AGREEMENT
Registration Rights Agreements
Eloxx Pharmaceuticals, Inc.
2010
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
2010
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2010
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2010
[End of text.]
Eloxx Pharmaceuticals, Inc.
2010
CONFIDENTIAL SEPARATIONAGREEMENT AND GENERAL RELEASE
Release Agreements
Eloxx Pharmaceuticals, Inc.
2010
CONFIDENTIAL SEPARATIONAGREEMENT AND GENERAL RELEASE
Release Agreements
Eloxx Pharmaceuticals, Inc.
2009
SENESCOTECHNOLOGIES, INC. STOCK OPTIONAGREEMENT
Stock Agreements
Eloxx Pharmaceuticals, Inc.
2009
SENESCOTECHNOLOGIES, INC. RESTRICTEDSTOCK UNIT ISSUANCE AGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2009
SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2009
SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2009
THISWARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISEARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THISWARRANT
Stock Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2009
THISWARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISEARE SUBJECT TO THE RESTRICTIONS ON TRANSFERSET FORTH IN SECTION 4 OF THISWARRANT
Stock Agreements
Eloxx Pharmaceuticals, Inc.
2009
THISWARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS
Stock Agreements
Eloxx Pharmaceuticals, Inc.
2009
THISWARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISEARE SUBJECT TO THE RESTRICTIONS ON TRANSFERSET FORTH IN SECTION 4 OF THISWARRANT
Stock Agreements
Eloxx Pharmaceuticals, Inc.
2009
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
2009
EXHIBIT10.2 SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2009
THISWARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS
Stock Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2009
THISWARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISEARE SUBJECT TO THE RESTRICTIONS ON TRANSFERSET FORTH IN SECTION 4 OF THISWARRANT
Stock Agreements
Eloxx Pharmaceuticals, Inc.
2009
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
2009
SENESCO TECHNOLOGIES, INC. 2008 INCENTIVECOMPENSATION PLAN
Eloxx Pharmaceuticals, Inc.
2009
Proposal for manufactureand supply of cGMP Polyribonucleotide Duplex for Phase - I Clinical Trials
Supply Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2008
Proposal for Biodistribution and Repeat DoseToxicity Studies in Mice Submitted by: BioReliance 14920 Broschart Road Rockville, MD 20850 To: Cato Research Ltd. and Senesco...
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
2008
KBI BioPharma, Inc. Services Agreement
Services Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NC
2008
PLACEMENTAGENT WARRANT
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2008
Confidential Treatment Requested under 17C.F.R. 200.80(b)(4) and240.24b-2
Eloxx Pharmaceuticals, Inc.
2008
SUPPLY AGREEMENT
Supply Agreements
Eloxx Pharmaceuticals, Inc.
2008
SECURITY AGREEMENT
Security Agreements
Eloxx Pharmaceuticals, Inc.
2008
AMENDMENT NO. 1 TO FINANCIAL ADVISORY AGREEMENT
Advisory Agreements
Eloxx Pharmaceuticals, Inc.
2008
LICENSEAGREEMENT between BAYER CROPSCIENCE AG and SENESCOTECHNOLOGIES, INC.
Eloxx Pharmaceuticals, Inc.
2007
ConfidentialTreatment has been requested for portions of this exhibit. The copy filedherewith omits the information subject to the confidentiality request. Omissions are...
Confidentiality Agreements
Eloxx Pharmaceuticals, Inc.
2007
Confidential Treatment has been requested forportions of this exhibit. The copy filed herewith omits the information subjectto the confidentiality request. Omissions are...
Confidentiality Agreements
Eloxx Pharmaceuticals, Inc.
2007
WARRANT SeriesA
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2007
WARRANT SeriesA
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2007
SENESCO TECHNOLOGIES, INC. SECURED CONVERTIBLE DEBENTURE
Debenture Agreements
Eloxx Pharmaceuticals, Inc.
2007
SENESCO TECHNOLOGIES, INC. SECURED CONVERTIBLE DEBENTURE
Debenture Agreements
Eloxx Pharmaceuticals, Inc.
2007
WARRANT SeriesB
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2007
WARRANT SeriesB
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2007
SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT
Eloxx Pharmaceuticals, Inc.
2007
[INSERT H.C.WAINWRIGHT LETTERHEAD]
Eloxx Pharmaceuticals, Inc.
2007
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Eloxx Pharmaceuticals, Inc.
2007
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Eloxx Pharmaceuticals, Inc.
2007
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Eloxx Pharmaceuticals, Inc.
2007
REGISTRATIONRIGHTS AGREEMENT
Registration Rights Agreements
Eloxx Pharmaceuticals, Inc.
2007
SECURITY AGREEMENT
Security Agreements
Eloxx Pharmaceuticals, Inc.
2007
COMMERCIAL LICENSE AGREEMENT
License Agreements
Eloxx Pharmaceuticals, Inc.
2007
LICENSE AGREEMENT between BAYER CROPSCIENCE GmbH and SENESCO TECHNOLOGIES, INC.
License Agreements
Eloxx Pharmaceuticals, Inc.
2007
STANFORD GROUPCOMPANY
Eloxx Pharmaceuticals, Inc.
2006
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Eloxx Pharmaceuticals, Inc.
2006
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Eloxx Pharmaceuticals, Inc.
2006
THIS WARRANT AND THE SHARES OFCOMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANT
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2006
H. C .WAINWRIGHT &CO., lNC. Investments Since 1868
Eloxx Pharmaceuticals, Inc.
2006
SENESCO TECHNOLOGIES, INC. WARRANT TO PURCHASE COMMONSTOCK
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2006
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUEDUPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THISWARRANT
Warrant Agreements
Eloxx Pharmaceuticals, Inc.
2005
Placement Agent Agreement
Eloxx Pharmaceuticals, Inc.
2005
SECURITIESPURCHASE AGREEMENT
Eloxx Pharmaceuticals, Inc.
2005